Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$472.00 USD
+0.56 (0.12%)
Updated Aug 15, 2024 04:00 PM ET
Pre-Market: $471.33 -0.67 (-0.14%) 8:32 AM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $4.11 | 0.31% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of -$12.83 per share, missing the Zacks Consensus Estimate of -$11.50 per share. This reflects a negative earnings surprise of 11.57%. Look out for VRTX's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of $4.11 per share, reflecting a year-over-year increase of .74%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex (VRTX) Stock Outperforms Industry YTD: Here's Why
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services